Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00319826 · ClinicalTrials.gov registry record
Virulence Determinants in S Aureus Bacteremia
A clinical trial of Bacteremia, sponsored by Duke University.
- Completed
- Registry status
- 1,354
- Enrollment target
- 1
- Study location
NCT00319826 is a study of Bacteremia that has completed, run by Duke University. The registered enrollment target is 1,354 participants, below the 7,454-participant average among 11 other Bacteremia trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00319826, a study of Bacteremia, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 1,354 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate why some people develop life-threatening infections caused by the bacteria Staphylococcus aureus, while other people do not. It is possible that the infectious ability of the bacteria can determine whether an infection develops and its severity. The investigators will look at old blood and nasal specimens collected from 1000 adults who had S. aureus infections and who were hospitalized at Duke University Medical Center. Previously collected health information regarding these patients and the specific bacterial traits in the samples will be studied. Eventually this information may be used to help treat and prevent S. aureus infection.
Conditions Studied
Interventions
- OTHER No intervention
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,354 participants |
| Start Date | 2004-03 |
| Est. Completion | 2013-08 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00319826
The ClinicalTrials.gov registry entry for NCT00319826 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,354 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 7,454-participant average among 11 other Bacteremia trials with a reported enrollment target (82% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bacteremia appearing as the primary indexed condition, and to 1 intervention - of which No intervention is the first listed.
NCT00319826 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00319826 about?
NCT00319826 is a clinical study titled "Virulence Determinants in S Aureus Bacteremia". The purpose of this study is to investigate why some people develop life-threatening infections caused by the bacteria Staphylococcus aureus, while other people do not. It is possible that the infectious ability of the bacteria can determine whether an infection develops and its severity. The invest...
What is the current status of trial NCT00319826?
This trial is currently completed. The enrollment target is 1,354 participants. The study started on 2004-03. Estimated completion is 2013-08.
What conditions does trial NCT00319826 study?
This clinical trial studies the following conditions: Bacteremia.
What interventions are being tested in trial NCT00319826?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT00319826?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00319826 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bacteremia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Reducing Risk for Infective Endocarditis
RECRUITING · NA
-
Evaluation of Emergency Medicine Pharmacist Impact on Blood Culture Review Following Emergency Department Discharge
RECRUITING
-
Monocyte Distribution Width (MDW) in the General Population of Emergency Department Patients With and Without Bacteremia
ACTIVE NOT RECRUITING
-
Antibiotic Administration and Blood Culture Positivity in Severe Sepsis and Septic Shock
COMPLETED
-
Bacteremia Antibiotic Length Actually Needed for Clinical Effectiveness
COMPLETED · NA
-
Multicenter Blood Culture Quality Improvement
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.